Admedus is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Its focus is on investing in and developing next generation technologies with world class partners and acquiring strategic assets to grow product and service offerings. The company has assets from research & development through clinical development and sales, marketing and distribution.


LATEST NEWS


The Market Herald – Admedus (ASX:AHZ) implants first patient with ADAPT 3D aortic valve
Admedus (AHZ) has implanted the first patient who has aortic stenosis with its ADAPT 3D aortic valve Aortic stenosis is...
Read more.

Admedus is pleased to announce that the first patient successfully implanted with ADAPT® treated 3D single piece ao… https://t.co/RueuF55hMa
Don't miss @themarketherald article! CEO Wayne Paterson discusses FIH study: " This trial will help us confirm the… https://t.co/sIRn63cd77
It was much appreciated that our very busy Doctors made time for our Virtual Advisory Board held last Friday. Prof… https://t.co/rFPbSMk7DN